S126 Dupilumab efficacy in children with uncontrolled type 2 asthma analyzed by baseline high or medium ICS dose: LIBERTY ASTHMA VOYAGE study

Autor: JF Maspero, MA Antila, N Jean, A Deschildre, LB Bacharier, A Altincatal, T Rimington, E Laws, B Akinlade, A Radwan, JA Jacob-Nara, Y Deniz, PJ Rowe, DJ Lederer, M Hardin

Publikováno v: ‘Finding Neverland’ – T2 inflammation and its absence.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8db03e80a9b649bf19f40e32eae548a7
https://doi.org/10.1136/thorax-2022-btsabstracts.132

P38 Dupilumab Improves Quality of Life in Caregivers of Children with Uncontrolled Moderate-to-Severe Asthma: Liberty Asthma Voyage Study

Autor: AG. Fiocchi, W. Phipatanakul, S. Durrani, J. Cole, J. Msihid, DJ. Lederer, M. Hardin, Y. Zhang, AH. Khan

Publikováno v: Value in Health. 25:S294-S295

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::05c8a227e892576c389ffa15aea0fd07
https://doi.org/10.1016/j.jval.2022.04.050

Association of OSA with Soluble Biomarkers of Lung and Vascular Injury: The Multi-Ethnic Study of Atherosclerosis.

Autor: Gottlieb DJ; VA Boston Healthcare System, Boston, MA, USA.; Brigham & Women's Hospital, Boston, MA, USA., Hansen SL; Department of Biostatistics, University of Washington, Seattle, WA, USA., McClelland RL; Department of Biostatistics, University of Washington, Seattle, WA, USA., Cornell E; University of Vermont Larner College of Medicine, Colchester, VT, USA., Kim JS; University of Virginia School of Medicine, Charlottesville, VA, USA., Tracy RP; University of Vermont Larner College of Medicine, Colchester, VT, USA., Lederer DJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Redline S; Brigham & Women's Hospital, Boston, MA, USA., Jelic S; Columbia University Medical Center, New York, NY, USA.

Publikováno v: Sleep [Sleep] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.

Dupilumab Induces Long-term On-Treatment Clinical Remission in Patients With Type 2 Asthma.

Autor: Pavord ID; NIHR Oxford Respiratory Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. Electronic address: ian.pavord@ndm.ox.ac.uk., Rabe KF; Lungen Clinic Grosshansdorf and Christian Albrechts University of Kiel, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany., Israel E; Department of Medicine, Harvard Medical School, Boston, Mass; Pulmonary and Critical Care Division, Brigham and Women's Hospital, Boston, Mass., Szefler SJ; Department of Pediatrics-Pulmonary Medicine, University of Colorado School of Medicine, Aurora, Colo., Brusselle G; Clinic of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium., Pandit-Abid N; Sanofi, Bridgewater, NJ., Altincatal A; Sanofi, Cambridge, Mass., Chen Z; Regeneron Pharmaceuticals Inc, Tarrytown, NY., Amin N; Regeneron Pharmaceuticals Inc, Tarrytown, NY., Khan AH; Sanofi, Chilly-Mazarin, France., Lederer DJ; Regeneron Pharmaceuticals Inc, Tarrytown, NY., Zhang Y; Regeneron Pharmaceuticals Inc, Tarrytown, NY., Rowe PJ; Sanofi, Bridgewater, NJ., Deniz Y; Regeneron Pharmaceuticals Inc, Tarrytown, NY., Radwan A; Regeneron Pharmaceuticals Inc, Tarrytown, NY., Jacob-Nara JA; Sanofi, Bridgewater, NJ., Busse WW; Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison, Wis.

Publikováno v: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.

Dupilumab Efficacy in Children With Type 2 Asthma Receiving High/Medium-Dose ICS (VOYAGE).

Autor: Maspero JF; Fundación CIDEA, Buenos Aires, Argentina. Electronic address: jorge.maspero@fundacioncidea.org.ar., Antila MA; Clínica de Alergía, Sorocaba, Sao Paulo, Brazil., Deschildre A; University Lille, CHU Lille, Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, 59000 Lille, France., Bacharier LB; Division of Allergy, Immunology and Pulmonary Medicine, Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn., Altincatal A; Sanofi, Cambridge, Mass., Laws E; Sanofi, Bridgewater, NJ., Mortensen E; Regeneron Pharmaceuticals Inc., Tarrytown, NY., Radwan A; Regeneron Pharmaceuticals Inc., Tarrytown, NY., Jacob-Nara JA; Sanofi, Bridgewater, NJ., Deniz Y; Regeneron Pharmaceuticals Inc., Tarrytown, NY., Rowe PJ; Sanofi, Bridgewater, NJ., Lederer DJ; Regeneron Pharmaceuticals Inc., Tarrytown, NY., Hardin M; Sanofi, Cambridge, Mass.

Publikováno v: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.